Brind.
  1. Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.

Goldman Sachs inquired about orthopedic market trends in August 2025.

2 reports, 1 independent Updated Aug 14
Gone quiet
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Goldman Sachs inquired about orthopedic market trends in August 2025.

Who's involved

What this event is mainly about
Goldman SachsZimmer Biomet Holdings

How it developed

Newest first. Tap a step to see who reported it.
  1. Financial analysts and investors questioned Zimmer Biomet regarding pricing trends, growth translation, and product integration.Sub-event
  2. Goldman Sachs inquired about orthopedic market trends.1 source

Keep exploring

Part of

Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.

Also in this story

All 12 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • StockStoryZimmer Biomet’s Q2 Earnings Call: Our Top 5 Analyst Questions Zimmer Biomet’s second quarter results were met with a positive market response, reflecting successful execution on new product launches
  • StockStoryZBH Q2 Deep Dive: New Product Launches and M&A Drive Guidance Upgrades Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2025, with sales up 7% year on ye